Stephanie G. Willis

2.5k total citations
32 papers, 1.8k citations indexed

About

Stephanie G. Willis is a scholar working on Hematology, Genetics and Rheumatology. According to data from OpenAlex, Stephanie G. Willis has authored 32 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Hematology, 18 papers in Genetics and 10 papers in Rheumatology. Recurrent topics in Stephanie G. Willis's work include Chronic Myeloid Leukemia Treatments (18 papers), Chronic Lymphocytic Leukemia Research (16 papers) and Eosinophilic Disorders and Syndromes (10 papers). Stephanie G. Willis is often cited by papers focused on Chronic Myeloid Leukemia Treatments (18 papers), Chronic Lymphocytic Leukemia Research (16 papers) and Eosinophilic Disorders and Syndromes (10 papers). Stephanie G. Willis collaborates with scholars based in United States, Germany and Australia. Stephanie G. Willis's co-authors include Michael W. Deininger, Brian Druker, Thomas O’Hare, Christopher A. Eide, Kara Johnson, Richard Devereux, Heather A. Bradeen, Francis Y. Lee, Thoralf Lange and Michael C. Heinrich and has published in prestigious journals such as Proceedings of the National Academy of Sciences, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Stephanie G. Willis

32 papers receiving 1.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Stephanie G. Willis United States	18	1.1k	871	593	397	181	32	1.8k
Graeme Smith United Kingdom	21	967 0.9×	632 0.7×	254 0.4×	387 1.0×	145 0.8×	61	2.1k
Kate J. Newberry United States	25	791 0.7×	951 1.1×	375 0.6×	1.0k 2.6×	157 0.9×	61	1.9k
E. Lie Norway	22	615 0.6×	147 0.2×	1.7k 2.9×	121 0.3×	139 0.8×	57	2.5k
Alessandro Cignetti Italy	22	290 0.3×	183 0.2×	66 0.1×	512 1.3×	47 0.3×	67	1.6k
Peter S. Kessler United States	13	351 0.3×	129 0.1×	95 0.2×	547 1.4×	76 0.4×	15	1.2k
Fanny Gaillard France	23	154 0.1×	382 0.4×	76 0.1×	256 0.6×	81 0.4×	50	1.8k
Serge Pissard France	21	748 0.7×	857 1.0×	80 0.1×	446 1.1×	86 0.5×	80	1.7k
Karen L. MacKenzie Australia	29	528 0.5×	231 0.3×	52 0.1×	1.4k 3.4×	129 0.7×	68	2.4k
Amy E. Anderson United Kingdom	22	108 0.1×	74 0.1×	342 0.6×	359 0.9×	264 1.5×	71	2.3k
Antonio García-Gómez Spain	24	438 0.4×	100 0.1×	73 0.1×	741 1.9×	52 0.3×	44	1.7k

Countries citing papers authored by Stephanie G. Willis

Since Specialization

Citations

This map shows the geographic impact of Stephanie G. Willis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stephanie G. Willis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stephanie G. Willis more than expected).

Fields of papers citing papers by Stephanie G. Willis

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stephanie G. Willis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stephanie G. Willis. The network helps show where Stephanie G. Willis may publish in the future.

Co-authorship network of co-authors of Stephanie G. Willis

This figure shows the co-authorship network connecting the top 25 collaborators of Stephanie G. Willis. A scholar is included among the top collaborators of Stephanie G. Willis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stephanie G. Willis. Stephanie G. Willis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Olson, Andrew, et al.. (2023). Characterization of antibiotic overuse for common infectious disease states at hospital discharge. SHILAP Revista de lepidopterología. 3(1). e229–e229. 2 indexed citations

Fleischman, Angela G., Takaomi Sanda, Alejandro Gutiérrez, et al.. (2011). Mutationally Activated TYK2 From T-ALL Specimens Exhibits Tranformative Capacity in Cell Lines and Primary Cell Models and T-Lineage Expansion in Mice. Blood. 118(21). 74–74. 2 indexed citations

Chang, Bill H., Stephanie G. Willis, Linda C. Stork, et al.. (2009). Mutational Analysis of BCR-Abl From Subjects with Relapsed Ph+ALL Treated On the COG Protocol AALL0031: a Report From the Children's Oncology Group.. Blood. 114(22). 2634–2634. 1 indexed citations

Tyner, Jeffrey, Marc Loriaux, Stephanie G. Willis, et al.. (2009). RAPID siRNA Screen for Identification of Therapeutic Gene Targets in Patients with Hematologic Malignancies.. Blood. 114(22). 3978–3978. 2 indexed citations

McWeeney, Shannon K., Gregory S. Yochum, Lucy Pemberton, et al.. (2009). A Gene Expression Signature of CD34+ Cells to Predict Major Cytogenetic Response in Chronic Phase Chronic Myeloid Leukemia Patients Treated with Imatinib: Potential Involvement of Beta-Catenin in Drug Resistance.. Blood. 114(22). 508–508. 1 indexed citations

Agarwal, Anupriya, Thomas G.P. Bumm, Amie S. Corbin, et al.. (2008). Absence of SKP2 expression attenuates BCR-ABL–induced myeloproliferative disease. Blood. 112(5). 1960–1970. 54 indexed citations

Sherbenou, Daniel W., Oliver Hantschel, Ines Kaupe, et al.. (2008). Characterization of BCR-ABL deletion mutants from patients with chronic myeloid leukemia. Leukemia. 22(6). 1184–1190. 31 indexed citations

Press, Richard D., Stephanie G. Willis, Jennifer Laudadio, Michael J. Mauro, & Michael W. Deininger. (2008). Determining the Rise in BCR-ABL RNA That Optimally Predicts a Kinase Domain Mutation in Patients with CML on Imatinib.. Blood. 112(11). 1108–1108. 1 indexed citations

Tyner, Jeffrey, Denise K. Walters, Stephanie G. Willis, et al.. (2007). RNAi screening of the tyrosine kinome identifies therapeutic targets in acute myeloid leukemia. Blood. 111(4). 2238–2245. 49 indexed citations

10.

Bradeen, Heather A., Christopher A. Eide, Thomas O’Hare, et al.. (2006). Comparison of imatinib mesylate, dasatinib (BMS-354825), and nilotinib (AMN107) in an N-ethyl-N-nitrosourea (ENU)–based mutagenesis screen: high efficacy of drug combinations. Blood. 108(7). 2332–2338. 317 indexed citations

11.

Crossman, Lucy C., Thomas O’Hare, Thoralf Lange, et al.. (2005). A single nucleotide polymorphism in the coding region of ABL and its effects on sensitivity to imatinib. Leukemia. 19(11). 1859–1862. 15 indexed citations

12.

Lange, Thoralf, Byung Park, Stephanie G. Willis, & Michael W. Deininger. (2005). BCR-ABL Kinase Domain Mutations in Chronic Myeloid Leukemia: Not Quite Enough to Cause Resistance to Imatinib Therapy?. Cell Cycle. 4(12). 1761–1766. 23 indexed citations

13.

Deininger, Michael W., Laura McGreevey, Stephanie G. Willis, et al.. (2004). Detection of ABL kinase domain mutations with denaturing high-performance liquid chromatography. Leukemia. 18(4). 864–871. 57 indexed citations

14.

Großmann, Arndt, Kathryn S. Kolibaba, Stephanie G. Willis, et al.. (2004). Catalytic domains of tyrosine kinases determine the phosphorylation sites within c‐Cbl. FEBS Letters. 577(3). 555–562. 13 indexed citations

15.

Rosée, Paul La, Kara Johnson, Amie S. Corbin, et al.. (2003). In vitro efficacy of combined treatment depends on the underlying mechanism of resistance in imatinib-resistant Bcr-Abl–positive cell lines. Blood. 103(1). 208–215. 82 indexed citations

16.

Riviere, George R., et al.. (1999). Phenotypic and Genotypic Heterogeneity among Cultivable Pathogen-Related Oral Spirochetes and Treponema vincentii. Journal of Clinical Microbiology. 37(11). 3676–3680. 12 indexed citations

17.

Hines, Mark E., Robert S. Evans, Barbara R. Sharak Genthner, et al.. (1999). Molecular Phylogenetic and Biogeochemical Studies of Sulfate-Reducing Bacteria in the Rhizosphere of Spartina alterniflora. Applied and Environmental Microbiology. 65(5). 2209–2216. 130 indexed citations

18.

Rooney‐Varga, Juliette N., Barbara R. Sharak Genthner, Richard B. Devereux, et al.. (1998). Phylogenetic and Physiological Diversity of Sulphate-Reducing Bacteria Isolated from a Salt Marsh Sediment. Systematic and Applied Microbiology. 21(4). 557–568. 36 indexed citations

19.

Mueller, James G., Richard Devereux, Deborah L. Santavy, et al.. (1997). Phylogenetic and physiological comparisons of PAH-degrading bacteria from geographically diverse soils. Antonie van Leeuwenhoek. 71(4). 329–343. 156 indexed citations

20.

Devereux, Richard, Stephanie G. Willis, & Mark E. Hines. (1997). Genome Sizes of Desulfovibrio desulfuricans , Desulfovibrio vulgaris , and Desulfobulbus propionicus Estimated by Pulsed-Field Gel Electrophoresis of Linearized Chromosomal DNA. Current Microbiology. 34(6). 337–339. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact